Platinum Investment Management LTD Atreca, Inc. Transaction History

Platinum Investment Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.61 - $5.2 $641,651 - $2.07 Million	-398,541 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$4.91 - $9.07 $400,282 - $739,422	81,524 Added 25.72%	398,541 $2.48 Million
Q2 2021 Aug 11, 2021	BUY	$7.82 - $13.8 $1.36 Million - $2.4 Million	173,743 Added 121.27%	317,017 $2.7 Million
Q1 2021 May 13, 2021	BUY	$13.0 - $19.34 $305,799 - $454,934	23,523 Added 19.64%	143,274 $2.2 Million
Q3 2020 Nov 13, 2020	BUY	$12.67 - $23.19 $1.52 Million - $2.78 Million	119,751 New	119,751 $1.67 Million

1.04M

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.